John Kairys

Concepts (95)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma
5
2011
227
0.990
Why?
Skin Neoplasms
5
2011
218
0.960
Why?
Internship and Residency
4
2009
233
0.720
Why?
General Surgery
4
2013
106
0.660
Why?
Lymph Nodes
4
2011
136
0.640
Why?
Parathyroid Glands
2
2006
9
0.610
Why?
Lymphatic Metastasis
5
2011
171
0.500
Why?
Workload
2
2009
32
0.500
Why?
Sentinel Lymph Node Biopsy
2
2009
60
0.470
Why?
Whole Body Imaging
1
2009
12
0.420
Why?
Clinical Competence
2
2009
270
0.410
Why?
Tomography, Emission-Computed
1
2009
42
0.410
Why?
Surgical Procedures, Operative
1
2008
55
0.370
Why?
Hyperparathyroidism, Primary
1
2006
5
0.350
Why?
Parathyroid Neoplasms
1
2006
15
0.340
Why?
Adenoma
1
2006
66
0.330
Why?
Melanocytes
1
2005
26
0.320
Why?
Hyperparathyroidism
1
2002
9
0.270
Why?
Submandibular Gland
1
2002
8
0.270
Why?
Lymphoscintigraphy
1
2002
3
0.260
Why?
Education, Medical, Graduate
3
2008
96
0.250
Why?
Radiopharmaceuticals
4
2011
152
0.230
Why?
Humans
14
2013
19249
0.210
Why?
Technetium Tc 99m Sestamibi
2
2006
13
0.150
Why?
United States
3
2009
1754
0.150
Why?
Esophageal Neoplasms
2
2007
98
0.140
Why?
Inventions
1
2013
4
0.140
Why?
Female
8
2011
9889
0.130
Why?
Biomedical Research
1
2013
95
0.130
Why?
Adenocarcinoma
2
2007
392
0.120
Why?
Molecular Imaging
1
2011
15
0.120
Why?
Middle Aged
6
2011
6027
0.110
Why?
Surgery, Computer-Assisted
1
2011
38
0.110
Why?
User-Computer Interface
1
2011
73
0.110
Why?
Imaging, Three-Dimensional
1
2011
149
0.110
Why?
Models, Anatomic
1
2009
28
0.100
Why?
Personnel Staffing and Scheduling
1
2008
34
0.100
Why?
Retrospective Studies
3
2011
1917
0.100
Why?
Models, Biological
1
2011
498
0.090
Why?
Specialties, Surgical
1
2007
16
0.090
Why?
Aged
5
2011
4649
0.090
Why?
Sensitivity and Specificity
2
2006
554
0.090
Why?
Vascular Surgical Procedures
1
2007
78
0.090
Why?
Teaching
1
2006
48
0.080
Why?
False Positive Reactions
1
2005
33
0.080
Why?
Lymph Node Excision
1
2005
66
0.080
Why?
Male
6
2011
9080
0.080
Why?
Physicians
1
2006
141
0.080
Why?
Time Factors
1
2008
1219
0.080
Why?
Neoplasms
1
2011
623
0.070
Why?
Adult
4
2011
5835
0.070
Why?
Ultrasonography
1
2006
226
0.070
Why?
Diagnosis, Differential
1
2005
470
0.070
Why?
Haptens
1
2003
14
0.070
Why?
Immunohistochemistry
1
2005
688
0.070
Why?
Cancer Vaccines
1
2003
49
0.070
Why?
Parathyroidectomy
1
2002
8
0.070
Why?
Parathyroid Hormone
1
2002
19
0.070
Why?
Hyperplasia
1
2002
62
0.070
Why?
Technetium Tc 99m Sulfur Colloid
1
2002
8
0.060
Why?
Stomach Neoplasms
1
2002
48
0.060
Why?
Aged, 80 and over
4
2011
1869
0.060
Why?
Guanylate Cyclase
1
2002
94
0.060
Why?
Predictive Value of Tests
1
2002
471
0.060
Why?
Neoplasm Metastasis
1
2002
270
0.060
Why?
Neoplasm Recurrence, Local
1
2003
325
0.060
Why?
Receptors, Peptide
1
2002
100
0.060
Why?
Gene Expression Regulation, Neoplastic
1
2002
460
0.050
Why?
Neoplasm Staging
2
2011
480
0.050
Why?
Prognosis
2
2011
823
0.040
Why?
Survival Rate
2
2011
398
0.040
Why?
Follow-Up Studies
2
2011
878
0.040
Why?
History, 19th Century
1
2013
49
0.030
Why?
Pennsylvania
1
2013
188
0.030
Why?
Drug Design
1
2011
54
0.030
Why?
Positron-Emission Tomography
1
2011
159
0.030
Why?
Computer Simulation
1
2011
195
0.030
Why?
Proportional Hazards Models
1
2007
201
0.020
Why?
Kaplan-Meier Estimate
1
2007
179
0.020
Why?
Personal Satisfaction
1
2006
13
0.020
Why?
Multivariate Analysis
1
2007
296
0.020
Why?
Task Performance and Analysis
1
2006
44
0.020
Why?
Analysis of Variance
1
2007
334
0.020
Why?
Attitude of Health Personnel
1
2006
192
0.020
Why?
Mycobacterium bovis
1
2003
3
0.020
Why?
Dinitrobenzenes
1
2003
5
0.020
Why?
Hypersensitivity, Delayed
1
2003
18
0.020
Why?
Antineoplastic Agents, Alkylating
1
2003
35
0.020
Why?
Cyclophosphamide
1
2003
66
0.020
Why?
Adjuvants, Immunologic
1
2003
37
0.020
Why?
Combined Modality Therapy
1
2003
358
0.020
Why?
Receptors, Guanylate Cyclase-Coupled
1
2002
97
0.020
Why?
Polymerase Chain Reaction
1
2002
257
0.020
Why?
RNA, Messenger
1
2002
629
0.010
Why?
Adolescent
1
2003
1765
0.010
Why?
Kairys's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (95)
Explore
_
Co-Authors (31)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_